ISELIN, N.J.--(BUSINESS WIRE)--Ephicacy Consulting Group, Inc. (“Ephicacy”), a leading biometrics Contract Research Organization (“CRO”), today announced that it has acquired Advance Research Associates (“ARA”), a provider of data management and biostatistical consulting services for clinical trials. The strategic acquisition enhances Ephicacy’s capabilities in the areas of biostatistics and data management, further strengthening the suite of solutions it offers to pharmaceutical, biotechnology, and medical device companies. Terms were not disclosed.
Since its founding in 2005, Ephicacy has grown into a leading biometrics Contract Research Organization (“CRO”) leveraging its global talent pool to deliver clinical analytics services. Ephicacy has a flexible service delivery approach offering both Functional Service Provider (“FSP”) and project-based solutions to its global client base.
As part of the transaction, ARA Founder and CEO Peter Shabe joins the Ephicacy team as Global Head of Biostatistics Consulting, along with a group of talented and experienced statisticians and data management experts from ARA.
“We are thrilled to welcome Peter and the rest of the talented ARA team to Ephicacy and to offer our clients the expertise that ARA has built over nearly three decades,” said Ganesh Gopal, CEO of Ephicacy. “Now, more than ever, drug developers need reliable partners who can help them navigate the complexities of data in clinical trials. This acquisition deepens our biostatistics and data management solutions and reinforces our ability to drive impactful outcomes for our clients and the patients they serve.”
Since its establishment in 1996, ARA has supported over 700 clinical trials by providing custom data management and biostatistical consulting services across pharmaceutical, biotech, medical device, and diagnostic companies.
“It is ARA’s mission to consistently provide the highest quality customized data management and biostatistical consulting services to our clients. Joining forces with Ephicacy represents a natural evolution of that mission,” said Peter Shabe, ARA Founder and Ephicacy’s incoming Global Head of Biostatistics Consulting. “Ephicacy shares our goals and core values, and I am eager to bring our collective expertise to the forefront of the health care industry.”
About Ephicacy Consulting Group, Inc.
Headquartered in Iselin, NJ, with employees and operations across North America and India, Ephicacy is a rapidly growing biometrics CRO, providing outsourced statistical programming, biostatistics, data management, and real-world evidence analytics services to pharmaceutical and biotechnology companies. Since its founding in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool to help global pharmaceutical and biotechnology companies reduce their time to market in a cost-effective manner. More information on the Company and its services can be viewed online at www.ephicacy.com.
